Browse > Article
http://dx.doi.org/10.14348/molcells.2014.0145

Homing and Restorative Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Cisplatin Injured Ovaries in Rats  

Liu, Jiabin (Liaoning Medical University)
Zhang, Haiying (Liaoning Medical University)
Zhang, Yun (Department of Gynecology and Obstetrics, Third Affiliated Hospital of Liaoning Medical University)
Li, Nan (Department of Gynecology and Obstetrics, Third Affiliated Hospital of Liaoning Medical University)
Wen, Yuku (Department of Gynecology and Obstetrics, Third Affiliated Hospital of Liaoning Medical University)
Cao, Fanglei (Department of Gynecology and Obstetrics, Third Affiliated Hospital of Liaoning Medical University)
Ai, Hao (Liaoning Medical University)
Xue, Xiaoou (Dongzhimen Hospital Affiliated to Beijing University of China Medicine)
Publication Information
Molecules and Cells / v.37, no.12, 2014 , pp. 865-872 More about this Journal
Abstract
Premature ovarian failure (POF) is a long-term adverse effect of chemotherapy treatment. However, current available treatment regimens are not optimal. Emerging evidence suggests that bone marrow-derived mesenchymal stem cells (BMSCs) could restore the structure and function of injured tissues, but the homing and restorative effects of BMSCs on chemotherapy injured ovaries are still not clear. In this study, we found that granulosa cell (GC) apoptosis induced by cisplatin was reduced when BMSCs were migrated to granulosa cells (GCs) in vitro. Chemotherapy-induced POF was induced by intraperitoneal injection of cisplatin in rats. BMSCs labeled with enhanced green fluorescent protein (EGFP) were injected into the rats via the tail vein to investigate the homing and distribution of BMSCs in vivo. The number of BMSCs in the ovarian hilum and medulla was greater than in the cortex, but no BMSCs were found in the follicles and corpus lutea. In addition, the BMSCs treatment group's antral follicle count and estradiol levels increased after 30 days, compared with the POF group. Hence, our study demonstrates that intravenously delivered BMSCs can home to the ovaries, and restore its structure and function in POF model rats.
Keywords
bone marrow-derived mesenchymal stem cells; cisplatin; homing; intravenous injection; premature ovarian failure;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhang, A., Wang, Y., Ye, Z., Xie, H., Zhou, L., and Zheng, S. (2010). Mechanism of TNF-${\alpha}$-nduced migration and hepatocyte growth factor production in human mesenchymal stem cells. J. Cell. Biochem. 111, 469-475.   DOI   ScienceOn
2 Tannock, I.F., Ahles, T.A., Ganz, P.A., and van Dam, F.S. (2004). Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J. Clin. Oncol. 22, 2233-2239.
3 Wang, S., Yu, L., Sun, M., Mu, S., Wang, C., Wang, D., and Yao, Y. (2013). The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure. Biomed Res. Int. 2013, 690491.
4 Yuan, L., Wu, M.J., Sun, H.Y., Xiong, J., Zhang, Y., Liu, C.Y., Fu, L.L., Liu, D.M., Liu, H.-Q., and Mei, C.-L. (2011). VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury. Am. J. Physiol. Renal. Physiol. 300, F207-F218.   DOI   ScienceOn
5 Nozaki, Y., Furubo, E., Matsuno, T., Fukui, R., Kizawa, K., Kozaki, T., and Sanzen, T. (2009). Collaborative work on evaluation of ovarian toxicity 6). Two-or four-week repeated-dose studies and fertility study of cisplatin in female rats. J. Toxicol. Sci. 34, SP73-81.
6 Ohishi, M., and Schipani, E. (2010). Bone marrow mesenchymal stem cells. J. Cell. Biochem. 109, 277-282.
7 Ruster, B., Grace, B., Seitz, O., Seifried, E., and Henschler, R. (2005). Induction and detection of human mesenchymal stem cell migration in the 48-well reusable transwell assay. Stem Cells Dev. 14, 231-235.   DOI   ScienceOn
8 Santos, N., Catao, C., Martins, N., Curti, C., Bianchi, M., and Santos, A. (2007). Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch. Toxicol. 81, 495-504.   DOI
9 Schmidt, A., Ladage, D., Schinkothe, T., Klausmann, U., Ulrichs, C., Klinz, F.J., Brixius, K., Arnhold, S., Desai, B., and Mehlhorn, U. (2006). Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24, 1750-1758.   DOI   ScienceOn
10 Selesniemi, K., Lee, H.-J., Niikura, T., and Tilly, J.L. (2009). Young adult donor bone marrow infusions into female mice postpone age-related reproductive failure and improve offspring survival. Aging 1, 49-57.
11 Liu, T., Huang, Y., Guo, L., Cheng, W., and Zou, G. (2012). CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure. Int. J. Med Sci. 9, 592-602.   DOI
12 Siddik, Z.H. (2003). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279.   DOI   ScienceOn
13 Sohni, A., and Verfaillie, C.M. (2013). Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013, 130763.
14 Takehara, Y., Yabuuchi, A., Ezoe, K., Kuroda, T., Yamadera, R., Sano, C., Murata, N., Aida, T., Nakama, K., Aono, F., et al. (2013). The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab. Invest. 93, 181-193.   DOI
15 Maruo, T., Laoag-Fernandez, J., Takekida, S., Peng, X., Deguchi, J., Samoto, T., Kondo, H., and Matsuo, H. (1999). Regulation of granulosa cell proliferation and apoptosis during follicular development. Gynecol. Endocrinol. 13, 410-419.   DOI
16 Lue, Y., Erkkila, K., Liu, P.Y., Ma, K., Wang, C., Hikim, A.S., and Swerdloff, R.S. (2007). Fate of bone marrow stem cells transplanted into the testis: potential implication for men with testicular failure. Am. J. Pathol. 170, 899-908.   DOI   ScienceOn
17 Morse, H., Elfving, M., Lindgren, A., Wolner-Hanssen, P., Andersen, C.Y., and Ora, I. (2013). Acute onset of ovarian dysfunction in young females after start of cancer treatment. Pediatr. Blood Cancer 60, 676-681.   DOI   ScienceOn
18 Maclaran, K., and Panay, N. (2011). Premature ovarian failure. J. Fam. Plann. Reprod. Health Care 37, 35-42.   DOI   ScienceOn
19 Miyamoto, Y., Shimada, K., Sakaguchi, Y., and Miyamoto, M. (2007). Cisplatin (CDDP)-induced acute toxicity in an experimental model of hepatic fibrosis. J. Toxicol. Sci. 32, 311-319.   DOI   ScienceOn
20 Matsuda, F., Inoue, N., Manabe, N., and Ohkura, S. (2011). Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells. J. Reprod. Dev. 58, 44-50.
21 Muscari, C., Bonafe, F., Martin-Suarez, S., Valgimigli, S., Valente, S., Fiumana, E., Fiorelli, F., Rubini, G., Guarnieri, C., Caldarera, C.M., et al. (2013). Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold. J. Cell. Mol. Med. 17, 518-530.   DOI
22 Nayernia, K., Lee, J.H., Drusenheimer, N., Nolte, J., Wulf, G., Dressel, R., Gromoll, J., and Engel, W. (2006). Derivation of male germ cells from bone marrow stem cells. Lab. Invest. 86, 654-663.   DOI   ScienceOn
23 Guo, J.Q., Gao, X., Lin, Z.J., Wu, W.Z., Huang, L.H., Dong, H.Y., Chen, J., Lu, J., Fu, Y.F., Wang, J., et al. (2013). BMSCs reduce rat granulosa cell apoptosis induced by cisplatin and perimenopause. BMC Cell Biol. 14, 1-9.   DOI
24 Iorio, R., Castellucci, A., Ventriglia, G., Teoli, F., Cellini, V., Macchiarelli, G., and Cecconi, S. (2014). Ovarian toxicity: from environmental exposure to chemotherapy. Curr. Pharm. Des. 20, 5388-5397.   DOI   ScienceOn
25 Johnson, J., Bagley, J., Skaznik-Wikiel, M., Lee, H.-J., Adams, G.B., Niikura, Y., Tschudy, K.S., Tilly, J.C., Cortes, M.L., Forkert, R., et al. (2005). Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 122, 303-315.   DOI   ScienceOn
26 Kupcova Skalnikova, H. (2013). Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95, 2196-2211.   DOI   ScienceOn
27 Lee, H.-J., Selesniemi, K., Niikura, Y., Niikura, T., Klein, R., Dombkowski, D.M., and Tilly, J.L. (2007). Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J. Clin. Oncol. 25, 3198-3204.   DOI   ScienceOn
28 Lai, D., Wang, F., Chen, Y., Wang, L., Wang, Y., and Cheng, W. (2013). Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility. BMC Dev. Biol. 13, 34.   DOI   ScienceOn
29 Lana, M.B.P., Straminsky, V., Onetto, C., Amuchastegui, J.M., Blanco, G., Galluzzo, L., Provenzano, S., and Nolting, M. (2010). What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma. Gynecol. Endocrinol. 26, 755-759.   DOI   ScienceOn
30 Lee, O., Coathup, M., Goodship, A., and Blunn, G. (2005). Use of mesenchymal stem cells to facilitate bone regeneration in normal and chemotherapy-treated rats. Tissue Eng. 11, 1727-1735.   DOI   ScienceOn
31 Bosch, P., Fouletier-Dilling, C., Olmsted-Davis, E., Davis, A., and Stice, S. (2006). Efficient adenoviral-mediated gene delivery into porcine mesenchymal stem cells. Mol. Reprod. Dev. 73, 1393-1403.   DOI   ScienceOn
32 Das, B., Antoon, R., Tsuchida, R., Lotfi, S., Morozova, O., Farhat, W., Malkin, D., Koren, G., Yeger, H., and Baruchel, S. (2008). Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. Neoplasia 10, 1105-1119.   DOI
33 Frenette, P.S., Pinho, S., Lucas, D., and Scheiermann, C. (2013). Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Ann. Rev. Immunol. 31, 285-316.   DOI   ScienceOn
34 Fu, X., He, Y., Xie, C., and Liu, W. (2008). Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy 10, 353-363.   DOI   ScienceOn
35 De Vos, F., Nuver, J., Willemse, P., van der Zee, A., Messerschmidt, J., Burgerhof, J., De Vries, E., and Gietema, J. (2004). Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy: cardiovascular risk factors and signs of vascular damage. Eur. J. Cancer 40, 696-700.
36 Donnez, J., and Dolmans, M.-M. (2013). Fertility preservation in women. Nat. Rev. Endocrinol. 9, 735-749.   DOI   ScienceOn
37 Forte, G., Minieri, M., Cossa, P., Antenucci, D., Sala, M., Gnocchi, V., Fiaccavento, R., Carotenuto, F., De Vito, P., Baldini, P.M., et al. (2006). Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24, 23-33.   DOI   ScienceOn
38 Ghadami, M., El-Demerdash, E., Zhang, D., Salama, S.A., Binhazim, A.A., Archibong, A.E., Chen, X., Ballard, B.R., Sairam, M.R., and Al-Hendy, A. (2012). Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure. PLoS One 7, e32462.   DOI   ScienceOn
39 Abd-Allah, S.H., Shalaby, S.M., Pasha, H.F., El-Shal, A.S., Raafat, N., Shabrawy, S.M., Awad, H.A., Amer, M.G., Gharib, M.A., El Gendy, E.A., et al. (2013). Mechanistic action of mesenchymal stem cell injection in the treatment of chemically induced ovarian failure in rabbits. Cytotherapy 15, 64-75.   DOI   ScienceOn
40 Bi, B., Schmitt, R., Israilova, M., Nishio, H., and Cantley, L.G. (2007). Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol.18, 2486-2496.   DOI   ScienceOn
41 Agung, M., Ochi, M., Yanada, S., Adachi, N., Izuta, Y., Yamasaki, T., and Toda, K. (2006). Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg. Sports Traumatol. Arthrosc. 14, 1307-1314.   DOI
42 Ai, H., Zhang, H., Zhang, Y., and Liu, Y. (2012). Mouse ovarian-related gene expression profiles change with intraperitoneal injection of cisplatin. African J. Pharm. Pharm. 6, 2119-2122.
43 Antoine, C., Ameye, L., Paesmans, M., and Rozenberg, S. (2013). Systematic review about breast cancer incidence in relation to hormone replacement therapy use. Climacteric 17, 116-135.
44 Kilic, S., Pinarli, F., Ozogul, C., Tasdemir, N., Naz Sarac, G., and Delibasi, T. (2013). Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty. Gynecol. Endocrinol. 30, 135-140.